ProEd Communications Expands Regulatory Consulting and Market Access Services for Life Sciences Companies through a New Hire and an Agency Partnership

NEW YORK--(BUSINESS WIRE)--

ProEd Communications, Inc. announces the expansion of its regulatory and market access services through the appointment of John Sall, PharmD, PhD, as ProEd's Executive Vice President of Global Regulatory Services, and a partnership with the newly formed Guarino Haskins Market Access, LLC (GHMA). ProEd and GHMA are members of the Healthcare Consultancy Group (HCG), part of the DAS Group of Companies.

Dr. Sall, who joins ProEd after a 20-year career in clinical and regulatory affairs, was most recently a Global Regulatory Director for Stiefel, a GlaxoSmithKline Company. His prior experience includes roles of increasing responsibility with AbbVie, Inc., Hospira, Inc., Cephalon, Inc., Novartis Pharmaceuticals Corp., and GlaxoSmithKline. He succeeds Dr. Mary Rofael, who was promoted to President of ProEd.

For more than 20 years, ProEd has provided expert scientific and strategic direction in medical affairs, publications, and regulatory communications for pharmaceutical, biotechnology, and medical device companies. In his new role, Dr. Sall will build on ProEd's industry leadership in guiding more than 120 client teams through FDA Advisory Committee Meetings, EU oral hearings, and other critical regulatory interactions. He will drive ProEd's growing clinical development and regulatory services, and help build compelling value propositions for clients' products.

"Dr. Sall is a dynamic leader and a great addition to the team," said ProEd's President, Dr. Mary Rofael. "His infectious enthusiasm and energy, combined with his creativity and deep experience, will be of tremendous benefit to our clients and will help them develop earlier and more valuable relationships with regulators, payers, patients, and other stakeholders."

In partnership with ProEd's newly formed sister agency, Guarino Haskins Market Access, LLC, Dr. Sall will lead the development of ProEd's global value dossier service.

Market access, the discipline of defining and communicating the unique value provided by medications and medical devices, is becoming increasingly important in today's rapidly changing healthcare marketplace. To address this growing need, HCG has launched Guarino Haskins Market Access, LLC, a new company that will combine the experience of leading market access professionals with the power of award-winning creative talent, to assist clients with consulting and policy analysis, marketing, and health economic outcomes research (HEOR) communications.

About ProEd

Founded in 1991, ProEd Communications, Inc. is a full-service health science and regulatory communications company with offices in Beachwood, OH, Basking Ridge, NJ, and New York City. ProEd's reputation is built on more than 2 decades of experience developing quality communication products aimed at improving patient outcomes. ProEd blends insights and understanding of unmet needs and educational gaps with scientific information to guide the development of evidence-based data dissemination for a vast array of products, biologics, devices, and nutritionals. Founded in 1998, ProEd Regulatory provides strategic and regulatory consulting, medical writing and design, communications coaching, project management, and patient advocacy to support clients' regulatory approval programs.

About Guarino Haskins Market Access

Guarino Haskins Market Access LLC is an integrated strategic consultancy and advertising company specializing in market access, which is the discipline of defining and communicating the unique value provided by medications and medical devices. With offices in Los Angeles and New York City, the agency is part of the Healthcare Consultancy Group (HCG) and a member of the DAS Group of Companies.

About Healthcare Consultancy Group (HCG)

The Healthcare Consultancy Group is a collaboration of agencies that enable healthcare companies' medical affairs, regulatory, and marketing teams to better meet the needs of physicians, patients, and other stakeholders. HCG firms provide strategic and communications consulting, scientific branding and messaging, data visualization, and traditional and digital creative execution. HCG agencies develop and execute medical publication plans, stakeholder relationship and peer-to-peer education programs, regulatory communication plans, market access initiatives, and patient-centered development and communications programs. Headquartered in New York, and with offices throughout the United States and the United Kingdom, HCG agencies include Health Science Communications, Hyphen Digital, The Scienomics Group, The Chameleon Group, ProEd Communications and ProEd Regulatory, Accuverus, Scientific Strategy Partners, and Guarino Haskins Market Access LLC. HCG and its agencies are members of the DAS Group of Companies.

About the DAS Group of Companies

The DAS Group of Companies, a division of Omnicom Group Inc. OMC (www.omnicomgroup.com), is a global group of marketing services companies. DAS includes over 200 companies in the following marketing disciplines: specialty, PR, healthcare, CRM, events, promotional marketing, branding and research. Operating through a combination of networks and regional organizations, DAS serves international, regional, national and local clients through more than 700 offices in 71 countries.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150819005912/en/